{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:18:41Z","timestamp":1760347121817},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>N6-methyladenosine (m6A) modification is involved in tumorigenesis and progression as well as closely correlated with stem cell differentiation and pluripotency. Moreover, tumor progression includes the acquisition of stemness characteristics and accumulating loss of differentiation phenotype. Therefore, we integrated m6A modification and stemness indicator mRNAsi to classify patients and predict prognosis for LGG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed consensus clustering, weighted gene co-expression network analysis, and least absolute shrinkage and selection operator Cox regression analysis to identify an m6A regulation- and mRNAsi-related prognostic index (MRMRPI). Based on this prognostic index, we also explored the differences in immune microenvironments between high- and low-risk populations. Next, immunotherapy responses were also predicted. Moreover, single-cell RNA sequencing data was further used to verify the expression of these genes in MRMRPI. At last, the tumor-promoting and tumor-associated macrophage polarization roles of TIMP1 in LGG were validated by in vitro experiments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten genes (DGCR10, CYP2E1, CSMD3, HOXB3, CABP4, AVIL, PTCRA, TIMP1, CLEC18A, and SAMD9) were identified to construct the MRMRPI, which was able to successfully classify patients into high- and low-risk group. Significant differences in prognosis, immune microenvironment, and immunotherapy responses were found between distinct groups. A nomogram integrating the MRMRPI and other prognostic factors were also developed to accurately predict prognosis. Moreover, in vitro experiments illustrated that inhibition of TIMP1 could inhibit the proliferation, migration, and invasion of LGG cells and also inhibit the polarization of tumor-associated macrophages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings provide novel insights into understanding the interactions of m6A methylation regulation and tumor stemness on LGG development and contribute to guiding more precise immunotherapy strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-023-05328-7","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T15:02:19Z","timestamp":1685631739000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma"],"prefix":"10.1186","volume":"24","author":[{"given":"Guihua","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longwei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"5328_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/path.5133","author":"PO Guichet","year":"2018","unstructured":"Guichet PO, Masliantsev K, Tachon G, Petropoulos C, Godet J, Larrieu D, Milin S, Wager M, Karayan-Tapon L. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence. J Pathol. 2018. https:\/\/doi.org\/10.1002\/path.5133.","journal-title":"J Pathol"},{"key":"5328_CR2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103817","author":"T Liang","year":"2020","unstructured":"Liang T, Zhou X, Li P, You G, Wang F, Wang P, Feng E. DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas. Aging. 2020. https:\/\/doi.org\/10.18632\/aging.103817.","journal-title":"Aging"},{"key":"5328_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3389\/fonc.2020.01409","volume":"10","author":"W Yin","year":"2020","unstructured":"Yin W, Jiang X, Tan J, Xin Z, Zhou Q, Zhan C, Fu X, Wu Z, Guo Y, Jiang Z, et al. Development and validation of a tumor mutation burden-related immune prognostic model for lower-grade glioma. Front Oncol. 2020;10:1409. https:\/\/doi.org\/10.3389\/fonc.2020.01409.","journal-title":"Front Oncol"},{"issue":"1","key":"5328_CR4","doi-asserted-by":"publisher","first-page":"1806662","DOI":"10.1080\/2162402x.2020.1806662","volume":"9","author":"LG Richardson","year":"2020","unstructured":"Richardson LG, Nieman LT, Stemmer-Rachamimov AO, Zheng XS, Stafford K, Nagashima H, Miller JJ, Kiyokawa J, Ting DT, Wakimoto H, et al. IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice. Oncoimmunology. 2020;9(1):1806662. https:\/\/doi.org\/10.1080\/2162402x.2020.1806662.","journal-title":"Oncoimmunology"},{"key":"5328_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103008","author":"G Lombardi","year":"2020","unstructured":"Lombardi G, Barresi V, Castellano A, Tabouret E, Pasqualetti F, Salvalaggio A, Cerretti G, Caccese M, Padovan M, Zagonel V, et al. Clinical Management of Diffuse Low-Grade Gliomas. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12103008.","journal-title":"Cancers"},{"issue":"1","key":"5328_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176. https:\/\/doi.org\/10.1186\/s12943-019-1109-9.","journal-title":"Mol Cancer"},{"issue":"6","key":"5328_CR7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.18632\/aging.101856","volume":"11","author":"J Zhou","year":"2019","unstructured":"Zhou J, Wang J, Hong B, Ma K, Xie H, Li L, Zhang K, Zhou B, Cai L, Gong K. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma\u2014a retrospective study using TCGA database. Aging. 2019;11(6):1633\u201347. https:\/\/doi.org\/10.18632\/aging.101856.","journal-title":"Aging"},{"key":"5328_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR. Rethinking m(6)A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;33:319\u201342. https:\/\/doi.org\/10.1146\/annurev-cellbio-100616-060758.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"5328_CR9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3389\/fonc.2019.01038","volume":"9","author":"Y Su","year":"2019","unstructured":"Su Y, Huang J, Hu J. m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gastric cancer. Front Oncol. 2019;9:1038. https:\/\/doi.org\/10.3389\/fonc.2019.01038.","journal-title":"Front Oncol"},{"issue":"10","key":"5328_CR10","first-page":"2156","volume":"9","author":"X Zhao","year":"2019","unstructured":"Zhao X, Cui L. Development and validation of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma. Am J Cancer Res. 2019;9(10):2156\u201369.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"5328_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kami\u0144ska B, Huelsken J, Omberg L, Gevaert O, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338-354.e315. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034.","journal-title":"Cell"},{"key":"5328_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F, Tan HB. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.009.","journal-title":"Cancer Lett"},{"issue":"8","key":"5328_CR13","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482\u201392. https:\/\/doi.org\/10.1093\/annonc\/mdw168.","journal-title":"Ann Oncol"},{"key":"5328_CR14","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fonc.2020.01444","volume":"10","author":"J Pan","year":"2020","unstructured":"Pan J, Xu L, Pan H. Development and validation of an m6A RNA methylation regulator-based signature for prognostic prediction in cervical squamous cell carcinoma. Front Oncol. 2020;10:1444. https:\/\/doi.org\/10.3389\/fonc.2020.01444.","journal-title":"Front Oncol"},{"issue":"1","key":"5328_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53. https:\/\/doi.org\/10.1186\/s12943-020-01170-0.","journal-title":"Mol Cancer"},{"issue":"5","key":"5328_CR16","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.7150\/thno.52717","volume":"11","author":"W Chong","year":"2021","unstructured":"Chong W, Shang L, Liu J, Fang Z, Du F, Wu H, Liu Y, Wang Z, Chen Y, Jia S, et al. m(6)A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer. Theranostics. 2021;11(5):2201\u201317. https:\/\/doi.org\/10.7150\/thno.52717.","journal-title":"Theranostics"},{"issue":"4","key":"5328_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.20892\/j.issn.2095-3941.2020.0402","volume":"17","author":"X Shen","year":"2020","unstructured":"Shen X, Hu B, Xu J, Qin W, Fu Y, Wang S, Dong Q, Qin L. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics. Cancer Biol Med. 2020;17(4):937\u201352. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0402.","journal-title":"Cancer Biol Med"},{"key":"5328_CR18","doi-asserted-by":"publisher","first-page":"594112","DOI":"10.3389\/fcell.2020.594112","volume":"8","author":"S Xu","year":"2020","unstructured":"Xu S, Tang L, Dai G, Luo C, Liu Z. Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas. Front Cell Dev Biol. 2020;8:594112. https:\/\/doi.org\/10.3389\/fcell.2020.594112.","journal-title":"Front Cell Dev Biol"},{"issue":"20","key":"5328_CR19","doi-asserted-by":"publisher","first-page":"20285","DOI":"10.18632\/aging.103800","volume":"12","author":"Z He","year":"2020","unstructured":"He Z, Long J, Yang C, Gong B, Cheng M, Wang Q, Tang J. LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21\/Smad7 and miR-23a\/PTEN axes. Aging. 2020;12(20):20285\u2013307. https:\/\/doi.org\/10.18632\/aging.103800.","journal-title":"Aging"},{"issue":"9","key":"5328_CR20","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1111\/jcmm.12579","volume":"19","author":"ZT Shen","year":"2015","unstructured":"Shen ZT, Wu XH, Li B, Shen JS, Wang Z, Li J, Zhu XX. CYP2E1 Rsa \u0399\/Pst \u0399 polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects. J Cell Mol Med. 2015;19(9):2136\u201342. https:\/\/doi.org\/10.1111\/jcmm.12579.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"5328_CR21","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s00204-016-1660-8","volume":"90","author":"L Pell\u00e9","year":"2016","unstructured":"Pell\u00e9 L, Cipollini M, Tremmel R, Romei C, Figlioli G, Gemignani F, Melaiu O, De Santi C, Barone E, Elisei R, et al. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma. Arch Toxicol. 2016;90(12):3099\u2013109. https:\/\/doi.org\/10.1007\/s00204-016-1660-8.","journal-title":"Arch Toxicol"},{"key":"5328_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lungcan.2019.01.003","volume":"130","author":"L La Fleur","year":"2019","unstructured":"La Fleur L, Falk-S\u00f6rqvist E, Smeds P, Berglund A, Sundstr\u00f6m M, Mattsson JS, Brand\u00e9n E, Koyi H, Isaksson J, Brunnstr\u00f6m H, et al. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11. Lung Cancer (Amsterdam, Netherlands). 2019;130:50\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2019.01.003.","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"1","key":"5328_CR23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41467-017-01730-x","volume":"8","author":"J Deng","year":"2017","unstructured":"Deng J, Chen H, Zhou D, Zhang J, Chen Y, Liu Q, Ai D, Zhu H, Chu L, Ren W, et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. Nat Commun. 2017;8(1):1533. https:\/\/doi.org\/10.1038\/s41467-017-01730-x.","journal-title":"Nat Commun"},{"issue":"3","key":"5328_CR24","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.3892\/ol.2018.7750","volume":"15","author":"K Xu","year":"2018","unstructured":"Xu K, Qiu C, Pei H, Mehmood MA, Wang H, Li L, Xia Q. Homeobox B3 promotes tumor cell proliferation and invasion in glioblastoma. Oncol Lett. 2018;15(3):3712\u20138. https:\/\/doi.org\/10.3892\/ol.2018.7750.","journal-title":"Oncol Lett"},{"issue":"1","key":"5328_CR25","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1038\/s41467-020-17279-1","volume":"11","author":"Z Xie","year":"2020","unstructured":"Xie Z, Janczyk P, Zhang Y, Liu A, Shi X, Singh S, Facemire L, Kubow K, Li Z, Jia Y, et al. A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma. Nat Commun. 2020;11(1):3457. https:\/\/doi.org\/10.1038\/s41467-020-17279-1.","journal-title":"Nat Commun"},{"issue":"1","key":"5328_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1054\/bjoc.2001.1854","volume":"85","author":"LL Groft","year":"2001","unstructured":"Groft LL, Muzik H, Rewcastle NB, Johnston RN, Kn\u00e4uper V, Lafleur MA, Forsyth PA, Edwards DR. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br J Cancer. 2001;85(1):55\u201363. https:\/\/doi.org\/10.1054\/bjoc.2001.1854.","journal-title":"Br J Cancer"},{"issue":"1","key":"5328_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/neuonc\/noq170","volume":"13","author":"M Crocker","year":"2011","unstructured":"Crocker M, Ashley S, Giddings I, Petrik V, Hardcastle A, Aherne W, Pearson A, Bell BA, Zacharoulis S, Papadopoulos MC. Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor. Neuro Oncol. 2011;13(1):99\u2013108. https:\/\/doi.org\/10.1093\/neuonc\/noq170.","journal-title":"Neuro Oncol"},{"issue":"5","key":"5328_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"6230","key":"5328_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204.","journal-title":"Science"},{"key":"5328_CR30","doi-asserted-by":"publisher","first-page":"608609","DOI":"10.3389\/fonc.2020.608609","volume":"10","author":"A Ghouzlani","year":"2020","unstructured":"Ghouzlani A, Rafii S, Karkouri M, Lakhdar A, Badou A. The promising IgSF11 immune checkpoint is highly expressed in advanced human gliomas and associates to poor prognosis. Front Oncol. 2020;10:608609. https:\/\/doi.org\/10.3389\/fonc.2020.608609.","journal-title":"Front Oncol"},{"issue":"10","key":"5328_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41585-019-0226-y","volume":"16","author":"AK Schneider","year":"2019","unstructured":"Schneider AK, Chevalier MF, Derr\u00e9 L. The multifaceted immune regulation of bladder cancer. Nat Rev Urol. 2019;16(10):613\u201330. https:\/\/doi.org\/10.1038\/s41585-019-0226-y.","journal-title":"Nat Rev Urol"},{"issue":"9","key":"5328_CR32","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2021.04.011","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang C, Li Y, Jia L, Kim JK, Li J, Deng P, Zhang W, Krebsbach PH, Wang CY. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021;28(9):1597-1613.e1597. https:\/\/doi.org\/10.1016\/j.stem.2021.04.011.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"5328_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.stem.2020.06.022","volume":"27","author":"L Jia","year":"2020","unstructured":"Jia L, Zhang W, Wang CY. BMI1 inhibition eliminates residual cancer stem cells after PD1 blockade and activates antitumor immunity to prevent metastasis and relapse. Cell Stem Cell. 2020;27(2):238-253.e236. https:\/\/doi.org\/10.1016\/j.stem.2020.06.022.","journal-title":"Cell Stem Cell"},{"key":"5328_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092361","author":"C Galassi","year":"2021","unstructured":"Galassi C, Musella M, Manduca N, Maccafeo E, Sistigu A. The immune privilege of cancer stem cells: a key to understanding tumor immune escape and therapy failure. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10092361.","journal-title":"Cells"},{"issue":"3","key":"5328_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1101\/gad.294348.116","volume":"31","author":"X Guo","year":"2017","unstructured":"Guo X, Zhao Y, Yan H, Yang Y, Shen S, Dai X, Ji X, Ji F, Gong XG, Li L, et al. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev. 2017;31(3):247\u201359. https:\/\/doi.org\/10.1101\/gad.294348.116.","journal-title":"Genes Dev"},{"issue":"2","key":"5328_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ccell.2017.07.006","volume":"32","author":"D Saha","year":"2017","unstructured":"Saha D, Martuza RL, Rabkin SD. Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade. Cancer Cell. 2017;32(2):253-267.e255. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.006.","journal-title":"Cancer Cell"},{"issue":"3","key":"5328_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s13402-022-00667-8","volume":"45","author":"K Mortezaee","year":"2022","unstructured":"Mortezaee K, Majidpoor J. Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy. Cell Oncol (Dordr). 2022;45(3):333\u201353. https:\/\/doi.org\/10.1007\/s13402-022-00667-8.","journal-title":"Cell Oncol (Dordr)"},{"key":"5328_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay1813","author":"S Taniguchi","year":"2020","unstructured":"Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N. Tumor-initiating cells establish an IL-33-TGF-\u03b2 niche signaling loop to promote cancer progression. Science. 2020. https:\/\/doi.org\/10.1126\/science.aay1813.","journal-title":"Science"},{"key":"5328_CR39","doi-asserted-by":"publisher","first-page":"984273","DOI":"10.3389\/fgene.2022.984273","volume":"13","author":"H Chi","year":"2022","unstructured":"Chi H, Jiang P, Xu K, Zhao Y, Song B, Peng G, He B, Liu X, Xia Z, Tian G. A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration. Front Genet. 2022;13:984273. https:\/\/doi.org\/10.3389\/fgene.2022.984273.","journal-title":"Front Genet"},{"issue":"1","key":"5328_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41467-020-20448-x","volume":"12","author":"D Liang","year":"2021","unstructured":"Liang D, Xue J, Geng L, Zhou L, Lv B, Zeng Q, Xiong K, Zhou H, Xie D, Zhang F, et al. Cellular and molecular landscape of mammalian sinoatrial node revealed by single-cell RNA sequencing. Nat Commun. 2021;12(1):287. https:\/\/doi.org\/10.1038\/s41467-020-20448-x.","journal-title":"Nat Commun"},{"issue":"1","key":"5328_CR41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-020-20598-y","volume":"12","author":"CL Wu","year":"2021","unstructured":"Wu CL, Dicks A, Steward N, Tang R, Katz DB, Choi YR, Guilak F. Single cell transcriptomic analysis of human pluripotent stem cell chondrogenesis. Nat Commun. 2021;12(1):362. https:\/\/doi.org\/10.1038\/s41467-020-20598-y.","journal-title":"Nat Commun"},{"issue":"1","key":"5328_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X, Dong Z. Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer. 2021;20(1):15. https:\/\/doi.org\/10.1186\/s12943-020-01305-3.","journal-title":"Mol Cancer"},{"key":"5328_CR43","doi-asserted-by":"publisher","first-page":"1056310","DOI":"10.3389\/fendo.2022.1056310","volume":"13","author":"H Chi","year":"2022","unstructured":"Chi H, Peng G, Yang J, Zhang J, Song G, Xie X, Strohmer DF, Lai G, Zhao S, Wang R, et al. Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma. Front Endocrinol (Lausanne). 2022;13:1056310. https:\/\/doi.org\/10.3389\/fendo.2022.1056310.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5328_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"5328_CR45","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351. https:\/\/doi.org\/10.1002\/pro.3715.","journal-title":"Protein Sci"},{"issue":"D1","key":"5328_CR46","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587-d592. https:\/\/doi.org\/10.1093\/nar\/gkac963.","journal-title":"Nucleic Acids Res"},{"key":"5328_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fonc.2020.00154","volume":"10","author":"G Tang","year":"2020","unstructured":"Tang G, Yin W. Development of an immune infiltration-related prognostic scoring system based on the genomic landscape analysis of glioblastoma multiforme. Front Oncol. 2020;10:154. https:\/\/doi.org\/10.3389\/fonc.2020.00154.","journal-title":"Front Oncol"},{"key":"5328_CR48","doi-asserted-by":"publisher","first-page":"1010044","DOI":"10.3389\/fgene.2022.1010044","volume":"13","author":"G Peng","year":"2022","unstructured":"Peng G, Chi H, Gao X, Zhang J, Song G, Xie X, Su K, Song B, Yang J, Gu T, et al. Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes. Front Genet. 2022;13:1010044. https:\/\/doi.org\/10.3389\/fgene.2022.1010044.","journal-title":"Front Genet"},{"key":"5328_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.omto.2021.06.011","volume":"22","author":"R Cao","year":"2021","unstructured":"Cao R, Ma B, Wang G, Xiong Y, Tian Y, Yuan L. Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer. Mol Ther Oncolytics. 2021;22:277\u201393. https:\/\/doi.org\/10.1016\/j.omto.2021.06.011.","journal-title":"Mol Ther Oncolytics"},{"issue":"24","key":"5328_CR50","doi-asserted-by":"publisher","first-page":"26095","DOI":"10.18632\/aging.202317","volume":"12","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhao H, Shi X, Jia X, Yang Y. Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer. Aging. 2020;12(24):26095\u2013120. https:\/\/doi.org\/10.18632\/aging.202317.","journal-title":"Aging"},{"issue":"1","key":"5328_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41419-020-03294-z","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wei X, Pan Y, Xu J, Si Y, Min Z, Yu B. A new risk factor indicator for papillary thyroid cancer based on immune infiltration. Cell Death Dis. 2021;12(1):51. https:\/\/doi.org\/10.1038\/s41419-020-03294-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5328_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Saut\u00e8s-Fridman C, Fridman WH, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5.","journal-title":"Genome Biol"},{"issue":"9","key":"5328_CR53","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9):e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468.","journal-title":"PLoS ONE"},{"key":"5328_CR54","doi-asserted-by":"publisher","first-page":"1018685","DOI":"10.3389\/fimmu.2022.1018685","volume":"13","author":"H Chi","year":"2022","unstructured":"Chi H, Xie X, Yan Y, Peng G, Strohmer DF, Lai G, Zhao S, Xia Z, Tian G. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC. Front Immunol. 2022;13:1018685. https:\/\/doi.org\/10.3389\/fimmu.2022.1018685.","journal-title":"Front Immunol"},{"issue":"7","key":"5328_CR55","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao YR, Zhang Q, Lei Q, Luo M, Xie GY, Wang H, Guo AY. ImmuCellAI: a unique method for comprehensive t-cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci (Weinh). 2020;7(7):1902880. https:\/\/doi.org\/10.1002\/advs.201902880.","journal-title":"Adv Sci (Weinh)"},{"key":"5328_CR56","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.02553","author":"MR Weiser","year":"2021","unstructured":"Weiser MR, Hsu M, Bauer PS, Chapman WC Jr, Gonz\u00e1lez IA, Chatterjee D, Lingam D, Mutch MG, Keshinro A, Shia J, et al. Clinical calculator based on molecular and clinicopathologic characteristics predicts recurrence following resection of stage I-III colon cancer. J Clin Oncol. 2021. https:\/\/doi.org\/10.1200\/jco.20.02553.","journal-title":"J Clin Oncol"},{"issue":"7","key":"5328_CR57","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888-1902.e1821. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"key":"5328_CR58","doi-asserted-by":"publisher","first-page":"908031","DOI":"10.3389\/fonc.2022.908031","volume":"12","author":"M Peng","year":"2022","unstructured":"Peng M, Zheng Z, Chen S, Fang L, Feng R, Zhang L, Tang Q, Liu X. Sensitization of non-small cell lung cancer cells to gefitinib and reversal of epithelial-mesenchymal transition by aloe-emodin via PI3K\/Akt\/TWIS1 signal blockage. Front Oncol. 2022;12:908031. https:\/\/doi.org\/10.3389\/fonc.2022.908031.","journal-title":"Front Oncol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-023-05328-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T15:04:33Z","timestamp":1685631873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-023-05328-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1186\/s12859-023-05328-7","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}